Paragon Capital Management (Utah)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,811
Closed -$747K 70
2023
Q2
$747K Sell
5,811
-4,057
-41% -$491K 0.63% 52
2023
Q1
$1.15M Buy
9,868
+5,035
+104% +$564K 1% 39
2022
Q4
$547K Buy
+4,833
New +$531K 0.51% 60
2022
Q2
Sell
-7,096
Closed -$908K 77
2022
Q1
$908K Sell
7,096
-2,860
-29% -$313K 0.84% 48
2021
Q4
$1.34M Buy
+9,956
New +$1.43M 1.14% 39

Other funds holding DXCM

Paragon Capital Management (Utah)'s DXCM Position: Q3 2023 in Review

Paragon Capital Management (Utah) sold out of DexCom (DXCM) in Q3 2023, closing a stake of 5,811 shares — an estimated $747K sold.

Paragon Capital Management (Utah) first reported a position in DXCM in Q4 2021 and held it in 5 quarters. The position peaked at $1.34M in Q4 2021. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Paragon Capital Management (Utah) reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Paragon Capital Management (Utah) sold 5,811 DexCom shares in Q3 2023, an estimated $747K.
  • Paragon Capital Management (Utah) first reported a position in DexCom in Q4 2021 and held it in 5 quarters.
  • Paragon Capital Management (Utah)'s DexCom position peaked at $1.34M in Q4 2021.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Paragon Capital Management (Utah)'s 13F filing for Q3 2023, filed 26 Sep 2024.